Biomaterial development for cardiopulmonary bypass.

Abstract

Cardiopulmonary bypass (CPB) is dependent on materials foreign to the patient for its successful application. When blood comes into contact with these so-called biomaterials, an inappropriate inflammatory response, which can be life-threatening in some patients, may develop. The reason for this inappropriate activation of host defence mechanisms is not… (More)

Topics

  • Presentations referencing similar topics